Date published: 2025-10-11

00800 4573 8000

SCBT Portrait Logo
Seach Input

SNX17 Inibidores

SNX17 Inhibitors are a class of chemical compounds designed to target and inhibit the function of Sorting Nexin 17 (SNX17), a member of the sorting nexin family involved in endosomal trafficking and receptor recycling. SNX17 plays a crucial role in mediating the endocytosis and subsequent recycling of various cell surface receptors, including integrins and low-density lipoprotein receptors, back to the plasma membrane. By binding to these receptors, SNX17 helps maintain their proper localization and function within the cell. The inhibition of SNX17 disrupts this process, leading to alterations in receptor trafficking, which can impact various cellular functions, including cell adhesion, migration, and signal transduction.

The study of SNX17 Inhibitors provides valuable insights into the mechanisms of receptor trafficking and the broader implications of endosomal sorting on cellular homeostasis. By selectively inhibiting SNX17, researchers can dissect the pathways that depend on proper receptor recycling and explore how disruptions in these pathways affect cellular behavior. This is particularly relevant in understanding how cells regulate their surface receptor composition in response to environmental cues or during processes like cell migration and immune responses. Additionally, SNX17 Inhibitors offer a tool to investigate the interactions between SNX17 and other proteins involved in endosomal sorting, revealing the complex network of interactions that govern intracellular trafficking. Overall, SNX17 Inhibitors serve as a crucial resource for studying the dynamic processes of endocytosis and receptor recycling, contributing to a deeper understanding of cellular regulation and the maintenance of cellular function.

VEJA TAMBÉM

Nome do ProdutoCAS #Numero de CatalogoQuantidadePrecoUso e aplicacaoNOTAS

BMH-21

896705-16-1sc-507460
10 mg
$165.00
(0)

Este composto também inibe a dinamina e pode, por conseguinte, perturbar a endocitose, afectando potencialmente o ciclo do PSGL1 nos endossomas.

MRT67307

1190378-57-4sc-507433
10 mg
$234.00
(0)

O MRT67307 inibe a TBK1 e a IKKε, que desempenham papéis no tráfico endossómico, particularmente em relação à formação de autofagossomas.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$260.00
$799.00
36
(2)

Ao ligar-se à actina, a latrunculina A interrompe a polimerização da actina. O citoesqueleto de actina é essencial para muitos processos endocíticos.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

Este composto interrompe a polimerização dos microtúbulos. Os microtúbulos são cruciais para o transporte de vesículas e o tráfico endossómico.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$60.00
$108.00
21
(1)

A clorpromazina inibe a endocitose mediada pela clatrina, influenciando potencialmente as rotas do tráfico endossómico.

5-(N-Ethyl-N-isopropyl)-Amiloride

1154-25-2sc-202458
5 mg
$102.00
20
(1)

A 5-(N-etil-N-isopropil)amilorida é um potente inibidor da macropinocitose, um processo intimamente relacionado com a endocitose e o tráfico endossómico.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$152.00
$515.00
(1)

A monensina é um ionóforo que perturba o tráfico endossomal-lisossomal. Este facto pode influenciar a expressão da SNX33 devido à perturbação da triagem de proteínas.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$56.00
$256.00
113
(3)

O 3-MA inibe a PI3K, conhecida por afetar a autofagia. Dada a relação entre endossomas e autofagossomas, a expressão da SNX33 pode ser influenciada.

Niclosamide

50-65-7sc-250564
sc-250564A
sc-250564B
sc-250564C
sc-250564D
sc-250564E
100 mg
1 g
10 g
100 g
1 kg
5 kg
$37.00
$77.00
$184.00
$510.00
$1224.00
$5814.00
8
(1)

A niclosamida inibe a SNX8 ao interferir com o seu papel na sinalização Wnt, levando à perturbação da ordenação da carga endossómica.